JP2018517767A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018517767A5 JP2018517767A5 JP2018513701A JP2018513701A JP2018517767A5 JP 2018517767 A5 JP2018517767 A5 JP 2018517767A5 JP 2018513701 A JP2018513701 A JP 2018513701A JP 2018513701 A JP2018513701 A JP 2018513701A JP 2018517767 A5 JP2018517767 A5 JP 2018517767A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- polypeptide
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims 12
- 229920001184 polypeptide Polymers 0.000 claims 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims 10
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 9
- 238000000034 method Methods 0.000 claims 4
- 210000004378 sebocyte Anatomy 0.000 claims 3
- 208000017520 skin disease Diseases 0.000 claims 3
- 238000012217 deletion Methods 0.000 claims 2
- 230000037430 deletion Effects 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 238000012261 overproduction Methods 0.000 claims 2
- 210000002374 sebum Anatomy 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 230000004132 lipogenesis Effects 0.000 claims 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000008742 seborrheic dermatitis Diseases 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562168374P | 2015-05-29 | 2015-05-29 | |
| US62/168,374 | 2015-05-29 | ||
| PCT/CA2016/050605 WO2016191864A1 (en) | 2015-05-29 | 2016-05-27 | Polypeptides and antibodies to treat skin conditions associated with overproduction of sebum |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018517767A JP2018517767A (ja) | 2018-07-05 |
| JP2018517767A5 true JP2018517767A5 (enExample) | 2019-06-20 |
| JP6853239B2 JP6853239B2 (ja) | 2021-03-31 |
Family
ID=57439738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018513701A Active JP6853239B2 (ja) | 2015-05-29 | 2016-05-27 | 皮脂の過剰産生に関連する皮膚疾病を処置するためのポリペプチド及び抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11117939B2 (enExample) |
| EP (1) | EP3307317B1 (enExample) |
| JP (1) | JP6853239B2 (enExample) |
| KR (1) | KR20180012833A (enExample) |
| CN (1) | CN107921125B (enExample) |
| HK (1) | HK1245664B (enExample) |
| WO (1) | WO2016191864A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107325157B (zh) * | 2017-08-07 | 2020-06-26 | 温州千瑞生物科技有限公司 | 调节皮脂分泌的肽以及包含其的化妆品 |
| KR102268921B1 (ko) * | 2019-12-10 | 2021-06-23 | 강원대학교산학협력단 | p53을 활성화하는 펩타이드를 포함하는 조성물 |
| KR102084163B1 (ko) * | 2019-12-27 | 2020-05-15 | 주식회사 인투앱 | 프로피오니박테리움 아크네스 균으로부터 유래한 지방산 분해 효소에 특이적으로 결합하는 신규한 항체 및 이의 용도 |
| EP4215178A1 (en) | 2020-09-11 | 2023-07-26 | Chemyunion Ltda | Composition, use of the composition, cosmetic method and method for modulating the production of sebum |
| CN117003829A (zh) * | 2023-07-24 | 2023-11-07 | 成都凯捷多肽科技有限公司 | 一种控油多肽化合物、制备方法及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007289063A (ja) * | 2006-04-25 | 2007-11-08 | Shiseido Co Ltd | しみ部位亢進遺伝子群を指標とした皮膚しみ形成予知方法、皮膚しみ形成抑制剤のスクリーニング方法 |
| CA2677264C (en) * | 2007-02-02 | 2021-11-30 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic disorders |
| WO2009121176A1 (en) * | 2008-03-31 | 2009-10-08 | The University Of British Columbia | Insulin-induced gene (insig) peptide compositions and methods for cytoprotection |
| ES2601827T3 (es) | 2009-02-24 | 2017-02-16 | Arava Bio-Tech Ltd. | Agentes antagonistas de visfatina para el tratamiento del acné y de otras afecciones |
| JP2011225455A (ja) * | 2010-04-15 | 2011-11-10 | Kao Corp | Ｓｒｅｂｐ抑制剤 |
| JP5353848B2 (ja) * | 2010-09-24 | 2013-11-27 | 株式会社アドヴィックス | 車両用ブレーキ装置 |
| CA2850836A1 (en) * | 2011-10-15 | 2013-04-18 | Genentech, Inc. | Methods of using scd1 antagonists |
| KR101910419B1 (ko) * | 2012-02-10 | 2018-10-23 | 애경산업(주) | 피지생성 억제용 화장료 조성물 |
| JP5947061B2 (ja) * | 2012-02-29 | 2016-07-06 | 花王株式会社 | Ｓｒｅｂｐ１抑制剤 |
| KR101528770B1 (ko) * | 2013-06-13 | 2015-06-15 | 코스맥스 주식회사 | 사과 유래 폴리페놀을 함유하는 피지분비 완화 및 여드름 증상 개선용 화장료 조성물 |
-
2016
- 2016-05-27 WO PCT/CA2016/050605 patent/WO2016191864A1/en not_active Ceased
- 2016-05-27 JP JP2018513701A patent/JP6853239B2/ja active Active
- 2016-05-27 EP EP16802284.6A patent/EP3307317B1/en active Active
- 2016-05-27 CN CN201680039396.8A patent/CN107921125B/zh active Active
- 2016-05-27 HK HK18105412.9A patent/HK1245664B/en unknown
- 2016-05-27 KR KR1020177037904A patent/KR20180012833A/ko not_active Ceased
- 2016-05-27 US US15/576,747 patent/US11117939B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ibraheem et al. | Administration strategies for proteins and peptides | |
| JP2018517767A5 (enExample) | ||
| MX2024010140A (es) | Nuevos metodos. | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| BR112014007086A2 (pt) | proteínas de função dual para o tratamento de distúrbios metabólicos | |
| JP2012041342A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| MX2012011776A (es) | Nuevos compuestos para tratamiento de enfermedades asociadas con proteinas amiloides o tipo amiloide. | |
| JP2017532343A5 (enExample) | ||
| JP2013136622A5 (enExample) | ||
| NZ603028A (en) | Tfpi inhibitors and methods of use | |
| JP2016508123A5 (enExample) | ||
| CA3044797C (en) | TREATMENT OF NEUROLOGICAL DISEASES | |
| BR112015027269A2 (pt) | terapia com bacteriófagos | |
| MX385860B (es) | Peptido para usarse para reducir la necesidad de cirugía en pacientes que tienen hiperplasia prostática beningna. | |
| MY178445A (en) | Novel antibody binding to tfpi and composition comprising the same | |
| JP2017532965A5 (enExample) | ||
| SA519410993B1 (ar) | النشاط المضاد للبكتيريا لأوليجو سكاريد من جالاكتو وزيليتول في العلاجات الجلدية | |
| CA2986891C (en) | Compositions for use in treating parkinson's disease and related disorders | |
| EA201790563A1 (ru) | Применение реслизумаба для лечения эозинофильной астмы со степенью тяжести от умеренной до тяжелой | |
| RU2017128296A (ru) | Композиция для лечения бесплодия | |
| JP2016513650A5 (enExample) | ||
| EA201892536A1 (ru) | Фармацевтические носители, содержащие микрорнк, для применения в лечении фиброзных заболеваний, вызванных гипергликемией | |
| BR112019009511A2 (pt) | polipeptídeo isolado, formulação, medicamento, uso de pelo menos um polipeptídeo, e, método de tratamento. | |
| PH12015502005A1 (en) | New stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy |